Founded in 2017 by two respiratory clinicians following 11 yrs of NHS-led and funded research.
To improve the lives of patients with chronic lung conditions by helping them to predict and prevent lung attacks and avoid hospital admissions.
Proprietary prediction algorithms are constructed from patient – specific symptoms, lung function and biomarkers in blood and saliva.
Clinical studies demonstrated 97% reduction in hospital admissions using predict to prevent intervention as part of proactive self-management.
Patients, clinicians, hospitals, policy makers and Industry provide a robust eco-system to ensure our products remain cutting edge and competitive.
“I found it very straightforward… I’m not brilliant with electronics but yes I found it very easy very straightforward”
“I like to share my progress with my family …it gives them greater understanding of my condition”
“One of the things that I found most useful was to see the results of my daily diary , my results in graphic form, so easy to see”
“I’m more confident about my self-management”
“before I didn’t even look at the colour of my sputum or think about how I feel but I do now”
“it gives you more confidence and direction”
30 years+ experience in pharmaceutical industry, including extensive corporate development roles. Was ex-COO & President US Operations Vectura Group, playing key role in Activaero GmbH acquisition & Skyepharma merger. Is also Executive Chairman of hVIVO Ltd.
Respiratory physician and named inventor on patents. Held executive leadership roles in European Respiratory and British Thoracic Societies. Is external advisor to EC Horizon 2020 Personalising Healthcare and various pharmaceutical companies.
Respiratory physician, named inventor on patents. 10 years’ experience in managing project finances/records and research background in saliva diagnostics and prediction algorithm construction.
Experienced founder of UK start-up SW company. 15 years+ experience in innovative software solutions and specialist in AI and IoT driven applications in healthcare.
Extensive US and international commercialisation experience in a number of senior roles, including vice president sales and marketing of the US publicly held company Critical Therapeutics, Inc. and vice president, director of client service at McK Healthcare. Currently, EVP of Commercial and Business Development at Vectura Group plc.
No posts were found.
76 King Street,
Manchester, M2 4NH,
70 Conduit Street, London,
W1S 2GF, United Kingdom